Racing Is Off As $4.5 Billion British Horse Racing Industry Grapples With Horse Flu Outbreak

  • 📰 Forbes
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 53%

Business Business Headlines News

Business Business Latest News,Business Business Headlines

An outbreak of equine influenza has forced Britain's $4.5 billion horse racing industry to cancel all races for the 1st time since 1981

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 394. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

DSV's $4 billion offer for Panalpina gets shareholder cold shoulderDanish logistics company DSV's $4 billion-plus bid for Panalpina hit a road... 💙 I'll do your Twitter & facebook manage and grow real followers. Please order now. Twitter. Facebook. .
Source: Reuters - 🏆 2. / 97 Read more »

Exclusive: This Under 30 Just Raised $4 Million To Gamify Consumer ResearchYou’re not expecting to see a caricature of Drake when completing a major brand’s survey. Yet, using pop culture and humor, Perksy has managed to gamify market research for companies like Pepsico and Nickelodeon with stunning success. Youre tweeting this? You used to call me on the cellphone!! AditiGanju aakashganju navabhijeet
Source: Forbes - 🏆 394. / 53 Read more »

Exclusive: This Under 30 Just Raised $4 Million To Gamify Consumer ResearchYou’re not expecting to see a caricature of Drake when completing a major brand’s survey. Yet, using pop culture and humor, Perksy has managed to gamify market research for companies like Pepsico and Nickelodeon with stunning success.
Source: Forbes - 🏆 394. / 53 Read more »

GlaxoSmithKline and Merck KGaA strike immunotherapy deal worth up to $4 billionU.K.-based GlaxoSmithKline Plc and Germany-based Merck KGaA are entering a partnership to develop and commercialize a therapy for patients with advanced non-small cell lung cancer in a deal worth up to $4.23 billion, the companies announced Tuesday.
Source: MarketWatch - 🏆 3. / 97 Read more »